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SafetyThe use of medicinal plants is an increasing phenomenon among the majority of people in many developing
countries. Some of the harvested medicinal plants are often stored for shorter or longer periods prior to
usage. Evidence from recent studies has demonstrated the pharmacological efﬁcacy of short and long-term
stored plant materials when compared to freshly-harvested ones. In an attempt to evaluate the effect of
long-term storage on the safety of some commonly used medicinal plants, the Ames test which involved
the use of three Salmonella typhimurium tester strains (TA98, TA100 and TA1535) were conducted. Current
ﬁndings indicate the absence of any mutagenic effects resulting from the storage of medicinal plant materials
for as long as 16 years. Although freshly collected Acokanthera oppositifolia extract demonstrated a mutagenic
effect against TA1535 strain at the highest concentration tested, no such effect was observed in the stored
material. Further studies involving metabolic activation systems and in vivo conditions may further elucidate
the effect of long-term storage on the safety of medicinal plants.
© 2013 SAAB. Published by Elsevier B.V. All rights reserved.1. Introduction
Globally, the increasing importance and potential of medicinal
plants remain evident (Newman et al., 2003; Gurib-Fakim, 2006). In
view of the numerous beneﬁts associated with the use of medicinal
plants, it has become widely accepted and now forms an integral part
of the culture in many developing countries including South Africa
(Mander et al., 2007). Much literature highlighting the rich biodiversity
and the popularity of medicinal plants in South Africa is available
(Hutchings et al., 1996; Mander et al., 2007; Van Wyk, 2011). Over the
past two decades, certain critical aspects of medicinal plant research in-
cluding their efﬁcacy, conservation and safety have received attention
(Fennell et al., 2004a,b; Verschaeve and Van Staden, 2008; Rybicki
et al., 2012). Presumably, the availability of such vital information will
be valuable in the formulation of effective policies geared towards en-
suring the successful integration of traditional medicine into a public
health framework (Alves and Rosa, 2007; Street et al., 2008).
In an attempt to alleviate the problem of overexploitation and
rapid depletion of plant biodiversity due to the heavy reliance on
plants collected from the wild by a burgeon of informal city dwellers
for therapeutic remedies, different approaches such as the cultiva-
tion and proper storage of medicinal plants have been recommended
(Fennell et al., 2004a; Wiersum et al., 2006). In addition, there is the
need for more research geared towards the better understanding of
the post-harvest physiology of medicinal plants (Fennell et al., 2004a).27 33 2605897.
by Elsevier B.V. All rights reservedThis is due to concerns regarding the pharmacological efﬁcacy ofmedic-
inal plants after an indeﬁnite period of storage. There is a possibility that
post-harvest processesmay cause chemical changes in the plants due to
the effects of oxidising enzymes, environmental and storage conditions
(Fennell et al., 2004a; Stafford et al., 2005). Therefore, it becomes perti-
nent to investigate the effect of storage on the pharmacology and toxi-
cology of medicinal plants. A number of researchers have critically
evaluated the effects of storage on the dynamics of plant secondaryme-
tabolites and the pharmacological efﬁcacies of medicinal plants (Griggs
et al., 2001; Stafford et al., 2005; Amoo et al., 2012a,b). Inmost cases, the
authors disclosed that medicinal plants could retain their pharmaco-
logical potency after different periods of time. Nevertheless, there is
a dearth of information, if any, on the safety of medicinal plants after
prolonged storage. Consequently, the present study evaluated the
potential mutagenic effects of 10 commonly used South African
medicinal plants which were stored for 12 or 16 years in comparison
to the freshly collected plant materials.
2. Materials and methods
2.1. Plant material collection and extract preparation
The list of plant species, plant parts, places of collection and voucher
specimen numbers of freshly harvested plants evaluated in this study is
shown in Table 1. The traditional medicinal usages of the selected plant
species, voucher specimen numbers of the stored material and their
places of collection have been documented in previous studies (Jäger
et al., 1996; McGaw et al., 2000). In order to eliminate environmental.
Table 1
Mutagenic activity of 10 long-term stored South African medicinal plants in terms of number of histidine (his+) independent revertants per plate using three Salmonella typhimurium tester strains.
Family Plant species Plant part(s) Place of collection Voucher number Conc (μg/ml) TA98 TA100 TA1535
Stored Fresh Stored Fresh Stored Fresh
Anacardiaceae Protorhus Leaves SNR S. Amoo 19 NUa 50 15 ± 2.4 17 ± 1.2 191 ± 9.5 173 ± 16.7 16 ± 2.0 16 ± 3.2
longifolia 500 16 ± 1.5 17 ± 2.8 197 ± 22.2 161 ± 4.6 14 ± 3.2 12 ± 0.3
(Bernh.) Engl. 5000 20 ± 3.5 18 ± 2.0 185 ± 14.3 169 ± 12.3 12 ± 1.7 16 ± 2.1
Apocynaceae Acokanthera Roots SNR A. Aremu 1 NUa 50 19 ± 2.7 20 ± 3.0 153 ± 12.7 150 ± 5.5 14 ± 2.0 16 ± 2.9
oppositifolia 500 21 ± 1.0 20 ± 3.5 163 ± 12.9 129 ± 3.2 14 ± 2.1 27 ± 16.7
(Lam.) Codd 5000 20 ± 2.0 36 ± 6.7 187 ± 6.2 120 ± 3.5 12 ± 1.0 184 ± 71.1
Asteraceae Artemisia Aerial UKZN S. Amoo 15 NUa 50 18 ± 3.2 18 ± 1.7 154 ± 12.3 155 ± 12.9 17 ± 1.7 14 ± 1.3
afra parts 500 15 ± 1.2 16 ± 0.9 134 ± 11.3 122 ± 15.5 16 ± 1.2 13 ± 1.8
Jacq. ex Willd 5000 22 ± 3.9 19 ± 1.8 125 ± 16.9 155 ± 10.7 16 ± 0.6 11 ± 1.5
Euphorbiaceae Spirostachys Leaves SNR S. Amoo 25 NUb 50 17 ± 0.7 23 ± 1.2 162 ± 6.4 154 ± 2.5 11 ± 2.3 15 ± 2.0
africana & Twigs 500 19 ± 0.9 20 ± 1.53 181 ± 17.7 151 ± 13.2 12 ± 1.5 15 ± 1.2
Sond. 5000 21 ± 2.2 18 ± 1.2 172 ± 14.6 164 ± 12.5 13 ± 2.1 13 ± 0.9
Lamiaceae Tetradenia Leaves UKZN S. Amoo 20 NUa 50 19 ± 2.4 15 ± 1.8 168 ± 4.1 163 ± 3.2 13 ± 1.2 14 ± 0.3
riparia 500 21 ± 3.6 18 ± 1.8 181 ± 6.4 183 ± 5.4 10 ± 0.9 13 ± 1.5
(Hochst.) Codd 5000 17 ± 0.7 23 ± 1.5 156 ± 6.9 181 ± 16.0 10 ± 1.7 10 ± 1.2
Lauraceae Ocotea Bark UKZN S. Amoo 13 NUa 50 20 ± 3.2 19 ± 1.7 142 ± 11.7 148 ± 11.5 14 ± 0.6 11 ± 1.5
bullata 500 19 ± 1.3 18 ± 0.9 172 ± 6.2 156 ± 15.6 16 ± 1.5 15 ± 2.9
(Burch.) Baill. 5000 19 ± 3.6 19 ± 2.0 178 ± 7.0 155 ± 9.8 15 ± 0.9 13 ± 1.9
Malvaceae Dombeya Leaves UKZN S. Amoo 11 NUb 50 21 ± 6.7 19 ± 0.3 206 ± 9.8 144 ± 9.2 14 ± 1.8 11 ± 0.6
rotundifolia 500 17 ± 0.6 14 ± 1.5 171 ± 2.6 141 ± 5.6 14 ± 2.3 14 ± 2.0
Hochst. 5000 21 ± 2.6 23 ± 5.0 194 ± 4.4 148 ± 10.4 13 ± 1.9 16 ± 4.1
Meliaceae Ekebergia Leaves SNR S. Amoo 22 NUa 50 21 ± 1.8 16 ± 1.3 165 ± 6.8 194 ± 17.9 11 ± 0.6 10 ± 0.6
capensis & Twigs 500 18 ± 1.3 16 ± 1.5 167 ± 8.3 169 ± 12.6 16 ± 1.5 13 ± 1.8
Sparrm 5000 20 ± 1.7 20 ± 3.0 171 ± 19.4 194 ± 16.1 14 ± 1.2 13 ± 0.6
Rhamnaceae Ziziphus Leaves SNR S. Amoo 17 NUa 50 22 ± 3.3 14 ± 0.9 141 ± 14.2 148 ± 3.8 11 ± 0.7 14 ± 2.7
mucronata 500 20 ± 2.4 18 ± 1.4 171 ± 16.9 165 ± 8.1 13 ± 0.7 12 ± 2.0
Willd. 5000 19 ± 2.0 14 ± 1.3 152 ± 4.7 163 ± 7.7 13 ± 1.5 14 ± 1.2
Rutaceae Clausena Leaves UKZN S. Amoo 18 NUb 50 18 ± 3.2 17 ± 1.2 179 ± 9.0 149 ± 12.5 12 ± 1.7 16 ± 0.1
Anisata (Willd.) & Twigs 500 12 ± 1.2 19 ± 1.7 185 ± 17.1 141 ± 10.3 10 ± 0.3 12 ± 3.7
Hook. F. ex Benth 5000 17 ± 1.5 17 ± 1.2 157 ± 10.0 167 ± 4.6 12 ± 1.5 14 ± 0.7
Solvent control (50% methanol) 15 ± 1.5 166 ± 12.0 14 ± 2.0
Positive control (4-nitroquinoline-1-oxide at 2 μg/plate) 294 ± 3.9 1583 ± 71.8 38 ± 3.7
Values are expressed as mean ± standard error where n = 6.
SNR = Silverglen Nature Reserve, Durban; UKZN = University of KwaZulu-Natal Botanical Garden, Pietermaritzburg.
a Voucher number of plant material stored for 16 years was as described by Jäger et al. (1996).

















97A.O. Aremu et al. / South African Journal of Botany 87 (2013) 95–98effects, the same set of plant materials was collected from the same
location and during the same season as the stored ones. The collected
plant materials were oven-dried at 50 °C and stored at room tem-
perature (25 °C) in dark conditions for 12 or 16 years. The freshly
harvested materials were similarly oven-dried at 50 °C. After identi-
ﬁcation by Dr C. Potgieter, voucher specimens were lodged in The
Bews Herbarium, University of KwaZulu-Natal, Pietermaritzburg,
South Africa.
For both stored and freshly collected plant species, the oven-dried
materials were ground into ﬁne powders through a 1 mm ring sieve
using an Ultra Centrifugal Mill (ZM 200, Retsch®, Germany). Plant
materials (1 g in 20 ml) were extractedwith 50%methanol in a sonica-
tion bath (Julabo GmbH, West Germany) containing ice-cold water for
1 h. Extracts were ﬁltered throughWhatman No.1 ﬁlter paper and con-
centrated in vacuo using a rotary evaporator (Bϋchi, Switzerland) at
40 °C. The concentrates were transferred to pre-weighed glass pill
vials and completely dried under a stream of air. Dried extracts were
dissolved in 50%methanol at a concentration of 5000 μg/ml and ﬁltered
through sterile 0.22 μm ﬁlters. Thereafter, two lower concentrations of
500 and 50 μg/ml were prepared.
2.2. Ames assay
Mutagenic potential of the extracts from the stored and freshly
collected plant materials was evaluated using the Ames Salmonella/
microsomemutagenicity assay, involving three Salmonella typhimurium
tester strains (TA98, TA100, TA1535) in the absence ofmetabolic activa-
tion (Maron and Ames, 1983; Mortelmans and Zeiger, 2000). For each
S. typhimurium tester strain, 100 μl of the bacteria was inoculated in
10 ml of Oxoid nutrient broth No. 2 for 16 h at 37 °C to obtain a density
of approximately 1 × 109 colony forming units per millilitre (CFU/ml).
In sterile test tubes (triplicate), 100 μl of the prepared sample was
added to 500 μl phosphate buffer (0.1 mM, pH 7.4) followed by
100 μl of overnight bacteria culture. Finally, 2 ml of melted top
agar (containing 10 mM histidine maintained at 50 °C) was added
to themixture in sterile test tubes. After vortexing, the test tube content
was poured in minimal agar plates and allowed to solidify (2–3 min).
The solvent control consisted of 50% methanol (100 μl/plate) while
4-nitroquinoline-N-oxide (4-NQO; Fluka Chemika, Switzerland) at
2 μg/plate was used as a positive control. After incubation at 37 °C
for 48 h, the colonies were counted using a colony counter (Anderman,
UK). The assay was conducted twice and results are expressed as a
mean (±standard error) number of reverted colonies per plate. An ex-
tractwas classiﬁed as amutagen if (i) the number of histidine (his+) re-
vertants was at least double that of the negative control and (ii) when
there was a dose dependent increase in the number of his+ revertants
(Cariello and Piegorsch, 1996).
3. Results and discussion
Based on the sensitivity, simplicity and affordability of the Ames
test, the assay remains one of the most common and widely accepted
methods for assessing the potential mutagenicity in several substances
and compounds (Mortelmans and Zeiger, 2000; Taylor et al., 2003;
Verschaeve andVan Staden, 2008). As an indication of the potentialmu-
tagenicity of the evaluated medicinal plants, the number of his+ rever-
tants obtained at 50, 500 and 5000 μg/ml for all the extracts is shown in
Table 1. Apart from the freshly collected Acokanthera oppositifolia ex-
tract at 5000 μg/ml which exhibited mutagenic effects against TA1535
tester strain, all the other plant extracts did not show any mutagenic
effect against the three tester bacterial strains. Mutagenic potential ob-
served with TA1535 tester is associated with the substitution of leucine
with proline in the bacterial genome (Mortelmans and Zeiger, 2000).
Generally, a positive response in any single bacterial strain either with
or without metabolic activation is sufﬁcient to designate a substance
as a mutagen (Zeiger, 2001). Therefore, necessary precautions mustbe exercised with the use of high concentration of A. oppositifolia espe-
cially when freshly collected. It is known that mutagenic substances or
compounds could potentially damage the germ line leading to fertility
problems and to mutations in future generations and may induce can-
cer (Mortelmans and Zeiger, 2000). The effect of storage on themutage-
nicity of a potential mutagen remains poorly understood in view of the
limited number of available studies (Pagano and Zeiger, 1985). As a
result, it is difﬁcult to accurately explain the non-mutagenic effect of
A. oppositifolia after prolonged storage, as observed in the current
study. Perhaps, the breakdown of constituent chemicals (Stafford et al.,
2005) in themedicinal plants after storage resulted in the current obser-
vation. Indeed, there was a signiﬁcant higher level of secondary me-
tabolites such as total phenolics, ﬂavonoids and gallotannins in freshly
collected A. oppositifolia extract compared to the stored one (Amoo
et al., 2012a). Although it is difﬁcult to establish a particular relationship
between the higher level of ﬂavonoid content and the observed muta-
genicity in freshly harvested A. oppositifolia, the likelihood that some
of the ﬂavonoids present are mutagenic cannot be eliminated. In fact,
certain ﬂavonoids, including quercetin, galangin and kaempferol are
mutagenic in some S. typhimurium strains as shown by the Ames test
(Boersma et al., 2000; Resende et al., 2012).
Toxicology testing is an essential requirement for the development
of modern pharmaceutical drugs. Such tests are also important for me-
dicinal plants. Therefore, the possible bacterial toxicity was assessed by
observing the background lawn of bacterial growth. The high likelihood
of the absence of toxicity in the evaluatedmedicinal plants (both stored
and fresh) was established with the presence of a granular thin ﬁlm
layer on the background lawn (Mortelmans and Zeiger, 2000). In addi-
tion, the number of his+ revertants observed in each of the tester
strains in any of the medicinal plants evaluated was not much lower
(perhaps half) than what was recorded in the solvent control.
4. Conclusions
Taken together, the currentﬁndings add to the available information
on the safety of medicinal plant consumption. The safety of medicinal
plants is one of the core issues of concern in the integration of tradition-
al medicine into primary health care systems. The current study indi-
cates the absence of any mutagenic effect resulting from the storage
of medicinal plants for a long time. In fact, the stored A. oppositifolia
was devoid of any mutagenic effect whereas the freshly collected
material demonstrated potential mutagenic effect against one of
the tester strains used. It seems logical to conclude that the majority
of these medicinal plants may be safe for use even after prolonged
storage. Nevertheless, further studies involving a battery of tests as
well as the use of S9 metabolic activation system and in vivo condi-
tions may further elucidate the effect of long-term storage on the
safety of medicinal plants.
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